Press Releases | Oncotarget.net

Oncotarget News

Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer

June 8, 2026

Taken together, these data obtained using pancreatic cancer cells with KRAS mutations suggest the ability of the PCAIs to prevent metastasis and tumor growth, strongly indicating their potential to serve... read more

Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer

Oncotarget

Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion

June 2, 2026

These results identify CTHRC1 as a key driver of CRC that may suppress the immune system, allowing for easier immune evasion by tumor cells, highlighting CTHRC1 as a potential new... read more

Oncotarget

Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy

May 13, 2026

Laryngeal leiomyosarcoma (LLMS) is an exceptionally rare malignant tumor, accounting for less than 1 % of all laryngeal cancers, which are predominantly epithelial in origin.”BUFFALO, NY - May 13, 2026 – A... read more

Oncotarget

Agentic AI Systems May Transform Nutritional Care in Oncology

May 11, 2026

Cancer-related malnutrition affects up to 80% of patients and contributes to 10 to 20% of cancer deaths.”BUFFALO, NY - May 11, 2026 – A new editorial was published in Volume 17... read more

Oncotarget

Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology

May 6, 2026

Gastrointestinal stromal tumors (GISTs) are molecularly defined by oncogenic alterations that predict clinical behavior and response to therapy.”BUFFALO, NY - May 6, 2026 – A new case report was published in... read more